ANGLE (LON:AGL) Receives “Buy” Rating from Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of ANGLE (LON:AGL) in a research report sent to investors on Wednesday, Marketbeat Ratings reports. They currently have a GBX 70 ($0.86) price target on the stock.

ANGLE Trading Up 3.6 %

Shares of AGL opened at GBX 14.50 ($0.18) on Wednesday. The business’s 50-day moving average price is GBX 14.24 and its 200 day moving average price is GBX 14.05. The company has a current ratio of 7.51, a quick ratio of 6.18 and a debt-to-equity ratio of 14.26. The stock has a market capitalization of £37.78 million, a P/E ratio of -161.11 and a beta of 0.20. ANGLE has a 1-year low of GBX 9.07 ($0.11) and a 1-year high of GBX 37.40 ($0.46).

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.